Cultivating pharma-grade cannabis
Our recently constructed cultivation facility in Portugal will supply our production with highest-quality cannabis grown in accordance with EU standards for pharmaceutical starting materials. This will help us secure consistent quality and supply.
75 years in pharmaceutical extraction
With our partners at Dr. Reckeweg we are able to leverage three generations of experience in botanical extraction and production to provide patients with the highest quality throughout our product portfolio.
Eurox Pharma is manufacturing Cannabis-based Medicines and products in a state-of-the-art facility in Germany. We take great pride in our premium products, produced according to the highest German and EU pharmaceutical quality and safety standards, and backed by cutting-edge research. Together with our partners we have a global distribution network.
Our core team has a broad knowledge base and extensive experience of European and German quality requirements and safety compliance. We work closely together with regulators and scientific and technical experts to ensure that our operations and products meet the highest quality and safety standards.
In Germany Cannabis-based Medicines are subject to medical prescription due to their classification as narcotic medicines. This means that we as a manufacturer are not allowed to pass on any detailed information about our product portfolio, including pictures, to the general public. However, specialists and pharmacists are welcome to contact us for more detailed information.
Please contact us on: email@example.com
Learn more about Eurox Products
If you are a doctor, pharmacist or another expert in the field of phytopharmacy, you can access detailed product information, scientific studies and guidelines in our expert area via the doccheck-login.
Research – A core task
Cannabis has been used for medical purposes for more than 5,000 years. Modern medical research has shown that Cannabis can treat and relieve the symptoms of a wide range of diseases. These include chronic pain, multiple sclerosis spasticity, chemotherapy-induced nausea and vomiting, and epilepsy.
However, the full potential of Cannabis-based Medicines has not been fully explored yet. Our research collaboration with the J.W. Goethe University Frankfurt contributes to further develop the targeted use of Cannabis-based Medicines for the benefit of patients with various conditions and symptoms.
In addition to the two main cannabinoids THC and CBD, the effects of other cannabinoids and terpenes are of great interest in order to offer a wide variety of therapeutic options.
Research and scientific development are a central part of our company philosophy. The continuous improvement and further development of our products enable doctors and patients to get an optimal therapy with Cannabis.
about cannabis based medicines
Cannabis contains so-called cannabinoids, the main plant active ingredients. To date, over 100 different cannabinoids have been identified, with the two best known (and most important) active ingredients being THC and CBD due to their natural concentration.
THC is the abbreviation for delta-9-tetrahydrocannabinol and is the most abundant active ingredient in cannabis. It is responsible for a variety of pharmacological effects and has a psychoactive effect.
CBD stands for cannabidiol and is the second most abundant compound. It does not have a psychoactive effect comparable to THC, but may help to mitigate its psychoactive effects.
Since the late 1980s, it has been known that the human body also has an endocannabinoid system that can influence a variety of psychological processes. Since its discovery, cannabinoid researchers have detected endocannabinoid receptors in the central nervous system (CNS), internal organs, connective tissue, glands, and immune cells.
There are a variety of cannabis strains. However, “Indica” and “Sativa” are probably the best known varieties, whereby Indica is said to have a calming effect and Sativa a more stimulating or activating effect.